Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$254K Buy
206,590
+130,537
+172% +$130K ﹤0.01% 3064
2026
Q1
$53.4K Sell
76,053
-268,553
-78% -$251K ﹤0.01% 3299
2025
Q4
$534K Sell
344,606
-44,465
-11% -$71K 0.01% 1529
2025
Q3
$615K Buy
389,071
+214,405
+123% +$373K 0.03% 918
2025
Q2
$381K Buy
+174,666
New +$423K 0.02% 1285
2025
Q1
Sell
-58,866
Closed -$245K 2839
2024
Q4
$245K Buy
+58,866
New +$222K 0.02% 1386

Other funds holding MXCT

XTX Topco's MXCT Position: Q2 2026 in Review

XTX Topco increased its MaxCyte (MXCT) stake by 172% in Q2 2026, buying an estimated $130K and bringing the position to 206,590 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #3064.

XTX Topco first reported a position in MXCT in Q4 2024 and has held it in 6 quarters since. The position peaked at $615K in Q3 2025. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • XTX Topco held 206,590 shares of MaxCyte worth $254K as of Q2 2026.
  • XTX Topco bought 130,537 MaxCyte shares in Q2 2026, an estimated $130K.
  • MaxCyte made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3064 holding.
  • XTX Topco first reported a position in MaxCyte in Q4 2024 and has held it in 6 quarters since.
  • XTX Topco's MaxCyte position peaked at $615K in Q3 2025.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.